Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Koconis currently holds 70,785 shares of Timber Pharmaceuticals, Inc. (TMBR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Koconis has been a net buyer of TMBR stock. They have purchased $7.6K and sold $0 worth of shares.
John Koconis's most recent insider trade was on Aug 20, 2023, when they sold 70,385 shares at $0.00 per share.
John Koconis serves as Executive at Timber Pharmaceuticals, Inc. (TMBR). They have executed 2 insider transactions totaling $7.6K over their tenure at the company.
John Koconis holds the position of Executive at Timber Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
John Koconis has shown a buying trading pattern, with $7.6K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by John Koconis was on Dec 15, 2021, when they purchased $7.6K worth of TMBR shares. This transaction involved 20,000 shares at $0.38 per share.
John Koconis currently owns 70,785 shares of Timber Pharmaceuticals, Inc. (TMBR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Koconis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Koconis has 2 Form 4 filings on record as an insider at Timber Pharmaceuticals, Inc..
Set alerts for John Koconis and 40,000+ other insiders.